Studies on the Metabolism and Hepatotoxicity of Coumarin in the Baboon
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Coumarin, a flavouring material, occurs naturally in many plants including the tonka bean, dates and a variety of fruits. Toxicity studies on this compound showed that coumarin was hepatotoxic in a number of species of animals, including the rat and dog (Hazleton et al., 1956; Hagan et al., 1967; Bar & Griepentrog, 1967) , and that there was considerable difference in species sensitivity. As a consequence the use of coumarin as a food additive has been discontinued.
However, it is becoming increasingly recognized that in the extrapolation of animal toxicity data in terms of human hazard, account must be taken of the metabolism of the compound in the test species and in man.
Kaighen &Williams (1961) showed ( 12 % of a dose of coumarin as 7-hydroxycoumarin and about 20 % as o-hydroxyphenylacetic acid. In the rat less than 1 % of the dose was converted into 7-hydroxycoumarin and about 20% into o-hydroxyphenylacetic acid. Further, it was found that coumarin enters the entero-hepatic circulation in the rat, Shilling et al. (1969) investigated the metabolism of coumarin in man and found that about 80% of the orally administered coumarin was excreted in urine during 24h as 7-hydroxycoumarin and only 1-6% as o-hydroxyphenylacetic acid.
This marked difference in the metabolic pattern of coumarin between man, on the one hand, and the rat and rabbit, on the other, called into question the validity of the animal toxicity data and suggested the desirability of conducting studies on a species of animal that metabolized coumarin in a manner similar to that in man.
The metabolic conversion of coumarin into 7-hydroxycoumarin was investigated in nine species of animal ( Table 2 ). The baboon was closest to man in its ability to convert coumarin into the 7-hydroxy derivative. This suggested investigation into the hepatotoxicity of coumarin in the baboon.
Coumarin was administered to one male and one female baboon at 50p.p.m. in the diet. The animals were kept on treatment for 3 weeks after which a bromsulphthalein excretion test was carried out and liver biopsy specimens were taken under anaesthesia.
The animals were then allowed to recover from anaesthesia and maintained on a control coumarin-free diet for 3 months. They were then treated with 100p.p.m. of coumarin in the diet for 3 weeks, at the end of which a second bromsulphthalein excretion test was carried out and liver biopsy specimens taken. The animals were again allowed to recover from anaesthesia and placed on control diet for a further 3 months, after which a third bromosulphthalein excretion test and liver biopsy were performed. Bromsulphthalein excretion tests were carried out on four untreated baboons and pieces of liver were obtained at post mortem. Histochemical, electron-microscopic and histological examinations were carried out on the liver biopsy specimens.
Results showed that bromsulphthalein excretion was prolonged in the female but not in the male after treatment at both dosages. It returned to normal after 3 months. No histological abnormalities were observed. Histochemically the lysosomes were larger than normal and dispersed throughout the liver cells after the period of treatment at both dosages. In control animals, and after a 3 months recovery period, these organelles appeared small, discrete and limited to the pericanalicular area of the liver cells. Ultrastructurally numerous autophagic vacuoles were observed, and both smooth and rough endoplasmic reticulum were dilated in the treated animals at both dosages. These were absent in control animals and in the treated animals after a 3 months recovery period.
The results of the bromsulphthalein excretion tests and the lysosomal changes
VOl. 2 seen are indicative of a hepatotoxic effect. Similar lysosomal and ultrastructural changes were observed in rats treated with 50 or 100p.p.m. of cournarin for 2 weeks. These changes were accompanied by liver enlargement and a marked depression of microsomal mixed-function oxidase activity. Thus it would appear that differences in the metabolic pattern of coumarin are not relevant to its hepatotoxicity.
